Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Infectious Disease Physician in Tampa, FL
NPI: 1467408591Primary Practice Location
TAMPA GENERAL HOSPITAL
1 Tampa General Cir, Tampa, FL
Primary Employer
University Medical Service Association Inc
health.usf.edu
HQ Phone
Get M.D. Beata's Phone Numberphone_androidMobile
Get M.D. Beata's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State License
2000 - 2026
American Board of Internal Medicine
Infectious Disease
HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa South
Fellowship • Infectious Disease
2003 - 2005
University of South Florida Morsani
Residency • Internal Medicine
2000 - 2003
Dr. Kiran C. Patel College of Osteopathic Medicine
osteopathic.nova.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 48 | 89 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 25 |
| 3 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 22 | 30 |
| 4 | 99221Initial hospital inpatient care, typically 30 minutes per day | 21 | 21 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 16 | 32 |
Authors: Chakrapol Sriaroon, Ricardo Restrepo-Jaramillo, Sally Alrabaa
Journal: BMJ Case Rep
Publication Date: 2018-06-04
Authors: Jamie Morano, Cristina Garcia, Anthony Cannella, Jose Montero
Journal: J Clin Tuberc Other Mycobact Dis
Publication Date: 2021-11-22
The epidemiology, demographics, and comorbidities of pulmonary and extra-pulmonary non-tuberculous mycobacterial infections at a large central Florida Academic Hospital.
Authors: Jamie Morano, Greg Matthew Teo, Anthony Cannella, Jose Montero
Publication Date: 2021-12-06
Lead Sponsor: ViiV Healthcare
Intervention / Treatment: BIOLOGICAL: GSK3810109A, BIOLOGICAL: Dolutegravir+lamivudine SOC regimen
Lead Sponsor: ViiV Healthcare
Collaborators: Janssen, LP
Intervention / Treatment: DRUG: Cabotegravir Tablets, DRUG: Rilpivirine Tablets, DRUG: Cabotegravir Injectable Suspension (CAB LA), DRUG: Rilpivirine Injectable Suspension (RPV LA), DRUG: BIKTARVY Tablets (BIK)
